Dotarem® is indicated for all types of MRI imaging procedures both in adults and in children. It was first launched on the French market in July 1989 and is now available in some 60 different countries. The product is supplied as bottles or pre-filled syringes.
Information about NSF
Artirem® was first launched in April 2003. This is the first product proposed on the market for osteoarticular exploration through local injection (intra-articular) of a contrast product. Artirem® is supplied as a pre-filled syringe.
Lumirem® is an oral or rectal solution used specifically for bowel marking during MRI examinations. Sold under license Advanced Magnetics.
Approved indications may vary depending on countries, please refer to the Prescribing Information approved in your country.